Master Protocol for Encorafenib/Binimetinib Continuation Sub-Studies (FLOTILLA Study, C4221026); Encorafenib and Binimetinib Continuation Sub-Study for Participants From the C4221008 (ARRAY-818-202; PHAROS) Study (C4221008C)
Clinical Trial Grant
Awarded By
Pfizer, Inc.
Start Date
July 11, 2025
End Date
July 13, 2030
Awarded By
Pfizer, Inc.
Start Date
July 11, 2025
End Date
July 13, 2030